Nine Plaintiffs File New Zantac Cancer Lawsuit in New Jersey
Nine plaintiffs have jointly filed a new Zantac cancer lawsuit in the U.S. District Court for the District of New Jersey. The plaintiffs have named…
FDA & Prescription Drugs
Plaintiffs File New Class Action Ranitidine Lawsuit Against Perrigo
Two plaintiffs—one from New York and the other from Virginia—recently filed a new generic Zantac (ranitidine) class-action lawsuit in the U.S. District Court for the…
Colorado Man Files New Zantac Lawsuit After Being Diagnosed with Bladder Cancer
Following a wave of Zantac and generic ranitidine recalls, a Colorado man has filed a new Zantac lawsuit against the manufacturers of the heartburn medication.…
Australian Regulators Find NDMA in 75 Percent of Zantac/Ranitidine
While Zantac (ranitidine) manufacturer Sanofi maintains that its product is safe, Australian drug regulators recently announced that three-quarters of the ranitidine samples they tested contained…
Under Pressure, Sanofi Recalls Zantac in U.S. and Canada
Amidst rising concerns that some medications may be contaminated with a potential cancer-causing agent, Zantac manufacturer Sanofi recently announced a recall of the heartburn medication…
FDA Announces Recall of Popular Heartburn Drug Amidst Contamination Concerns
On September 24, 2019, the Food and Drug Administration (FDA) alerted healthcare professionals and the public to a voluntary recall of 14 lots of prescription…
Pharmaceutical Companies Paid Billions to Doctors in 2018: Influencing Prescriptions?
According to a recent report by the Centers for Medicare and Medicaid Services (CMS), doctors and hospitals received even more money in 2018 from pharmaceutical…
Despite Risks of Death, FDA Approves Generic Uloric
In February 2019, the FDA warned that the gout medication Uloric (febuxostat), manufactured by Takeda Pharmaceuticals, created an increased risk of death from all causes.…
FDA Reveals Over 6 Million Previously Hidden Medical Device Adverse Event Reports
For about 20 years, the FDA has allowed some medical device manufacturers to shield reports of problems with their devices from the public eye. This…
FDA Says Allopurinol—not Uloric—Should be First-Line Treatment for Gout
Pharmaceutical company Takeda recently suffered a blow when the FDA determined that their medication, Uloric (febuxostat), should no longer be recommended as a first-line treatment…